Page last updated: 2024-11-03

primidone and Cerebral Pseudosclerosis

primidone has been researched along with Cerebral Pseudosclerosis in 1 studies

Primidone: A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.
primidone : A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Louis, ED1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Environmental Epidemiology of Essential Tremor[NCT04576676]1,497 participants (Actual)Observational2020-07-02Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for primidone and Cerebral Pseudosclerosis

ArticleYear
Clinical practice. Essential tremor.
    The New England journal of medicine, 2001, Sep-20, Volume: 345, Issue:12

    Topics: Adrenergic beta-Antagonists; Aged; Anticonvulsants; Benzodiazepines; Diagnosis, Differential; Electr

2001